Panel Discussion: Navigating the Field of Oncolytic Virus Partnering & Licensing
Time: 11:30 am
day: Day Two
Understand the Necessary Parameters for An Attractive Potential New Partner in The Field of Oncolytic Viruses with Examples from The Field
- What are the fundamental assets a biotech must have when approaching large pharma for a potential licensing agreement or acquisition proposition?
- Acquisition vs Licensing: Is there a preferential route for large pharma?
- Where will future innovation come from within the field of oncolytic viruses?